Expert blog

Aug. 15, 2017
References
  1. AskMayoExpert. Colorectal cancer. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Bailey HR, et al., eds. Management of rectal cancer. In: Colorectal Surgery. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed Jan. 4, 2017.
  3. Rectal cancer treatment (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/rectal/HealthProfessional. Accessed Dec. 30, 2016.
  4. Fischer J, et al. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades. International Journal of Colorectal Disease. 2015;30:797.
  5. Peres-Ruiz E, et al. Immunological landscape and clinical management of rectal cancer. Frontiers in Immunology. 2016;7:1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761957/. Accessed Feb. 22, 2017.
  6. Niederhuber JE, et al., eds. Cancer of the rectum. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Jan. 4, 2017.
  7. Etzioni DA, et al. Patient survival after surgical treatment of rectal cancer: Impact of surgeon and hospital characteristics. Cancer. 2014;120:2472.
  8. Renouf DJ, et al. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer. American Journal of Clinical Oncology. 2013;36:558.
  9. Colorectal cancer. American Cancer Society. https://www.cancer.org/cancer/colon-rectal-cancer.html. Accessed Jan. 4, 2017.
  10. Macrae FA, et al. Clinical presentation, diagnosis, and staging of colorectal cancer. http://www.uptodate.com/home. Accessed Feb. 4, 2016.
  11. Ryan DP, et al. Overview of the management of rectal adenocarcinoma. http://www.uptodate.com/home. Accessed Feb. 4, 2016.
  12. Mahipal A, et al. Role of biologics in first-line treatment of colorectal cancer. Journal of Oncology Practice. 2016:12:1219.
  13. Holman FA, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centers. European Journal of Surgical Oncology. 2017;43:107.
  14. Holman FA, et al. Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: A pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven. Journal of Gastrointestinal Oncology. 2016;7:903.
  15. Larson DW (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 30, 2016.